Literature DB >> 18946935

Fetal nasal bone length and Down syndrome during the second trimester in a Chinese population.

Jeng-Hsiu Hung1, Chong Yau Fu, Chih-Yao Chen, Kuan-Chong Chao, Jamie Hung.   

Abstract

OBJECTIVE: The purpose of the present study was to build a database of reference ranges of fetal nasal bone length (NBL) in a Chinese population. The accuracy rate of detecting Down syndrome was also analyzed using fetal NBL as a marker.
METHODS: The control group of fetuses included 342 normal singleton pregnancies with no chromosomal or congenital anomalies. The present study was a cross-section study and the control group was used to construct percentile values of NBL from 13 to 29 gestational weeks of age. Two-dimensional ultrasonography was used for the nasal bone studies. Measurements of NBL were collected and each fetus contributed a single value to the reference sample. During the study period, 14 fetuses with Down syndrome were examined. Measurement of fetal NBL was made during amniocentesis, with gestational age ranging from 13 to 19 weeks.
RESULTS: From 342 normal fetuses with gestational age ranging from 13 to 29 weeks, reference ranges of NBL were constructed. The reference ranges were constructed from the 100(1 - p)% reference range: Y +/- Zp x square root sigma 2, where Y = 25 - exp(3.58 - 0.044 x t + 0.0006 x t2), with Y being the fitted mean of regression model and t being gestational age (weeks). Using fetal NBL, the regression model was Pr(Down syndrome) = exp(W)/ [1 + exp(W)], where W = 0.62-4.80 x NBL (multiples of the median) in predicting Down syndrome. Fetal NBL was found to have a sensitivity and specificity of 0.78 and 0.78, respectively, in predicting Down syndrome in the second trimester of pregnancy.
CONCLUSIONS: Fetal NBL measurement can provide a simple and useful algorithm to predict Down syndrome during the second trimester of pregnancy.

Entities:  

Mesh:

Year:  2008        PMID: 18946935     DOI: 10.1111/j.1447-0756.2008.00747.x

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  6 in total

Review 1.  First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2017-03-15

Review 2.  First and second trimester serum tests with and without first trimester ultrasound tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2017-03-15

3.  Is Prenatal Diagnosis Necessary for Fetal Isolated Nasal Bone Absence or Hypoplasia?

Authors:  Jianbing Liu; Qiuwei Wang; Feng Zhang; Wei Long; Qin Zhou; Jing Wang; Ye Shi
Journal:  Int J Gen Med       Date:  2021-08-11

4.  Absent fetal nasal bone in the second trimester and risk of abnormal karyotype in a prescreened population of Chinese women.

Authors:  Yan Du; Yunyun Ren; Yingliu Yan; Li Cao
Journal:  Acta Obstet Gynecol Scand       Date:  2017-12-14       Impact factor: 3.636

5.  Prenatal chromosomal microarray analysis in foetuses with isolated absent or hypoplastic nasal bone.

Authors:  Xiaomei Shi; Jian Lu; Ling Li; Ran Wei; Jing Wu
Journal:  Ann Med       Date:  2022-12       Impact factor: 4.709

Review 6.  First trimester serum tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2015-11-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.